Ashraf Khan MD
Title Professor
Institution University of Massachusetts Medical School
Department Pathology
Division Anatomic Pathology
Address University of Massachusetts Medical School
One Innovation Drive, Biotech Three
Worcester MA 01605
Telephone 508-856-6214
Email
Other Positions
Institution UMMS - Graduate School of Biomedical Sciences
Department Cancer Biology
Narrative

Academic Background:

MBBS              JN Medical College, Aligarh University, Aligarh, INDIA

MD                 Pathology, JN Medical College, Aligarh University, Aligarh, INDIA

Residency       Histopathology, Lewisham & Guy’s Hospital, University of London, London,   UK

FRCPath           Histopathology, Royal College of Pathologists, London, UK

Fellowship        Surgical Pathology, University of Massachusetts Medical Center, Worcester, MA

Dr. Khan's pictureResearch Interests:

Dr. Ashraf Khan’s clinical interest includes diagnostic surgical pathology of Breast and Endocrine system. Dr. Khan is actively involved in clinical translational research focused in the field of thyroid and breast cancer investigating biomarkers that help in the diagnosis and prediction of outcome in these tumors. Over the past decade Dr. Khan has published several papers on the role of cell cycle regulatory proteins, translation initiation factors and cell adhesion molecules in the diagnosis of thyroid follicular tumors and progression of thyroid cancer. Dr. Khan was a key contributor of one large multi-institution international study published in The Lancet on the role of galectin 3 and CD44 in the diagnosis of thyroid malignancy. Dr. Khan’s collaboration with the basic scientists in the department of cancer biology at UMass has resulted in multiple projects including b4-integrin signature in basal-like breast cancer which was recently published and Sox-9 expression in breast cancer which is work in progress. In addition Dr. Khan is a PI on a Department of Defense Grant in collaboration with Dr. Leslie Shaw in department of cancer biology looking at the Insulin Receptor Substrate Proteins (IRS1 and IRS2) in breast cancer with special focus on potential role they may play in Herceptin resistance in HER-2 positive breast cancer. He is also currently involved in studying the micro RNA signature in breast cancer especially estrogen receptor positive node negative tumors with potential therapeutic implications. Dr. Khan is a member of the UMASS graduate school of biomedical sciences representing cancer biology.

Dr. Khan is the past President and Secretary of the Endocrine Pathology Society, a companion society of the US and Canadian Academy of Pathology. He is a reviewer for a number of pathology and endocrinology journals, serves on the editorial board of the journal Endocrine Pathology and is the Section Editor (Endocrine Pathology) of the Archives of Pathology and Laboratory Medicine. In addition to numerous original articles, Dr. Khan has authored many book chapters and invited reviews and is currently editing a text book on surgical pathology of endocrine tumors.

Publications
1. Buttar A, Mittal K, Khan A, Bathini V. Effective role of hormonal therapy in metastatic primary neuroendocrine breast carcinoma. Clin Breast Cancer. 2011 Oct; 11(5):342-5.
  View in: PubMed
 
2. Clark JL, Dresser K, Hsieh CC, Sabel M, Kleer CG, Khan A, Shaw LM. Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer. Breast Cancer Res Treat. 2011 Dec; 130(3):759-72.
  View in: PubMed
 
3. Karam AR, Nugent W, Khan A, Desai D, Shankar S. Curved stylet core biopsy results in larger cores. AJR Am J Roentgenol. 2010 Jul; 195(1):242-4.
  View in: PubMed
 
4. Virk RK, Khan A. Pseudoangiomatous stromal hyperplasia: an overview. Arch Pathol Lab Med. 2010 Jul; 134(7):1070-4.
  View in: PubMed
 
5. Karam AR, Nugent W, Falardeau J, Desai D, Khan A, Shankar S. Multifocal extra-adrenal myelolipoma arising in the greater omentum. J Radiol Case Rep. 2009; 3(11):20-3.
  View in: PubMed
 
6. Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Hum Pathol. 2009 Nov; 40(11):1528-33.
  View in: PubMed
 
7. Menon MP, Khan A. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol. 2009 Nov; 62(11):978-85.
  View in: PubMed
 
8. Jaffar R, Mohanty SK, Khan A, Fischer AH. Hemosiderin laden macrophages and hemosiderin within follicular cells distinguish benign follicular lesions from follicular neoplasms. Cytojournal. 2009; 6:3.
  View in: PubMed
 
9. Slosar M, Vohra P, Prasad M, Fischer A, Quinlan R, Khan A. Insulin-like growth factor mRNA binding protein 3 (IMP3) is differentially expressed in benign and malignant follicular patterned thyroid tumors. Endocr Pathol. 2009; 20(3):149-57.
  View in: PubMed
 
10. Lee CW, Simin K, Liu Q, Plescia J, Guha M, Khan A, Hsieh CC, Altieri DC. A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res. 2008; 10(6):R97.
  View in: PubMed
 
11. Lu S, Simin K, Khan A, Mercurio AM. Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clin Cancer Res. 2008 Feb 15; 14(4):1050-8.
  View in: PubMed
 
12. Nelson EJ, Chowdhury A, Harris JB, Begum YA, Chowdhury F, Khan AI, Larocque RC, Bishop AL, Ryan ET, Camilli A, Qadri F, Calderwood SB. Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea. Proc Natl Acad Sci U S A. 2007 Nov 27; 104(48):19091-6.
  View in: PubMed
 
13. Sharma V, Cui H, Whalen G, Khan A, Torres M. A case of trabecular adenoma of the thyroid with black pigmentation. Thyroid. 2007 Jun; 17(6):593-4.
  View in: PubMed
 
14. Istvanic S, Fischer AH, Banner BF, Eaton DM, Larkin AC, Khan A. Cell blocks of breast FNAs frequently allow diagnosis of invasion or histological classification of proliferative changes. Diagn Cytopathol. 2007 May; 35(5):263-9.
  View in: PubMed
 
15. Khan A, Vohra P, Quinlan RF. The role of sentinel lymph node biopsy in the management of breast cancer. Indian J Pathol Microbiol. 2007 Apr; 50(2):261-9.
  View in: PubMed
 
16. Schmidt M, Khan A, Schmidt AM, Heinze B, Hack E, Waltenberger J, Kreienberg R. A novel breast cancer cell line initially established from pleural effusion: evolution towards a more aggressive phenotype. Int J Oncol. 2007 Mar; 30(3):565-72.
  View in: PubMed
 
17. Rezk S, Khan A. Role of immunohistochemistry in the diagnosis and progression of follicular epithelium-derived thyroid carcinoma. Appl Immunohistochem Mol Morphol. 2005 Sep; 13(3):256-64.
  View in: PubMed
 
18. Ciampa A, Fanger G, Khan A, Rock KL, Xu B. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas. Cancer. 2004 Dec 25; 102(6):368-72.
  View in: PubMed
 
19. Rezk S, Yousef M, Zamansky M, Khan A. Solitary fibrous tumor of the auditory canal. Arch Pathol Lab Med. 2004 Dec; 128(12):e169-71.
  View in: PubMed
 
20. Khan A, Tischler AS, Patwardhan NA, DeLellis RA. Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study. Endocr Pathol. 2003; 14(3):249-55.
  View in: PubMed
 
For assistance with using Profiles, please refer to the online tutorials at http://inside.umassmed.edu/is/profiles.aspx or contact the UMMS Help Desk at UMWHelpDesk@umassmed.edu or 508-856-8643.
 
Keyword
Last Name
Institution
    
 
 
 
Co-Authors  
Fischer, Andrew
Karam, Adib
Rock, Kenneth
Simin, Karl
Torres, Mira
See all (15) people
Physical Neighbors  
Fischer, Andrew
Deng, April
Walter, Otto
Hao, Suyang
Vanguri, Vijay

UMMS Home

Intranet

This is an official Page/Publication of the University of Massachusetts Worcester Campus
Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572